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Summary
BACKGROUND: Reimbursement for inpatients in
Switzerland differed among states until 2012. Some hospit-
als used diagnosis related groups (DRG) and others used
fee-for-service (FFS). We compared length of hospital stay
(LOS), patient satisfaction and quality of life between the
two systems before a nation-wide implementation of DRG.
METHODS: In a prospective, two-centre observational co-
hort study, we identified all patients with a main diagnosis
of either community-acquired pneumonia, exacerbation of
chronic pulmonary obstructive disease, acute heart failure
or hip fracture from January to June 2011 and performed a
systematic questionnaire survey 2–4 months after hospital
discharge.
RESULTS: Of 1,093 inpatients, 450 were included. Mean
age was 71.1 (±SD 19.5) years (48% male). Patients in the
FFS hospital were older (mean age 74.8 vs. 65.2 years; p
<0.001) and suffered from more co-morbidities. Mean LOS
was 9 days and shorter in the all-patient DRG (AP-DRG)
hospital (unadjusted mean 8.2 vs. 9.5 days, p = 0.04). After
multivariate adjustment, no significant difference in LOS
was found (p = 0.24). More patients from the FFS hos-
pital were re-hospitalised for any reason (35% vs. 17.5%;
p = 0.01), re-admitted to acute-care institutions (11.7% vs.
5.2%; p = 0.014), not satisfied with the discharge process
(15.3% vs. 9.7%; p = 0.02), showed problems with self-
care (93.8% vs. 88%; p = 0.03) and usual activities (79.3%
vs. 76%; p = 0.02).
DISCUSSION: This study suggested that the AP-DRG
hospital showed higher patient satisfaction regarding dis-
charge, lower re-hospitalisation rates and shorter LOS
partly explained by a lower burden of co-morbidities and
disease severity. This study needs validation in a larger co-
hort of patients and at multiple time points.
Key words: DRG; length of stay; outcome; Fee-For-
Service; quality of care
Background
The increasing costs for medical treatment put an important
burden on societies world-wide. In 2010, the total national
health expenditures in the US amounted to $2.6 trillion,
which related to 17.6% of the gross national product (GNP)
[1]. In the same year, the annual cost in Switzerland
amounted to $62.5 translating into 11.4% of GNP [2]. A
large part of these costs are due to expensive inpatient treat-
ment and are directly correlated to length of hospital stays
(LOS) in fee-for-service (FFS) based systems. Shortening
LOS is thus an important measure for cost control. In addi-
tion, studies have found that shorter LOS may result in im-
proved patient outcomes, including lower risk for hospital
acquired infections and hospital-acquired disabilities, and
improved patient satisfaction [3, 4]. For these reasons dia-
gnosis related groups (DRG) based reimbursement systems
have been propagated, where hospitals are paid a lump sum
based on the patient’s condition, mainly independent of the
LOS [5]. However, the effects of such incentives on quality
of care and patients’ outcomes remain largely unknown and
an increase of so-called “bloody exits” is postulated, which
would be preterm discharge of patients not diagnosed and
treated properly. There is literature about this topic, mostly
from the United States and dating back to the 1980’s when
the country introduced a DRG system [6–8].
The beginning of the development of the DRG system star-
ted at Yale University in the 1970’s. The Swiss DRG is
based on the German (G-) DRG, which is based on the
Australian refined (AR-) DRG. The source of this Australi-
an version lies in the all-patient (AP-) DRG [9].
In Switzerland, although hospital remuneration was based
primarily on FFS before 2012, a smaller group of hospitals
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already used a reimbursement system similar to the AP-
DRG as a precursor of the SwissDRG introduced on Janu-
ary 1st, 2012. The AP-DRG system in Switzerland consists
of about 648 case groups. To put a patient into a case
group the following information is needed: main diagnosis,
secondary diagnoses, the surgical and diagnostic interven-
tions, the age, sex, the kind of discharge and, for newborns,
the birth weight. The aim of this information is to put pa-
tients into their appropriate case group. All patients in one
group are supposed to have a similar course of disease and
therapy [9] and are reimbursed by the same flat rate. The
coding of the diseases is based on ICD-10 (International
Classification of Diseases) and the CHOP (Swiss classific-
ation of surgical operations) [10].
A further advantage of the DRG is the possibility of bench-
marking among hospitals. In that way it is possible to com-
pare the severity of a patient’s disease by way of using the
case-mix-index (= mean cost weight of a hospital).
One of the challenges of the AP-DRG and the DRGs in
general is that the hospital may have a financial incentive
to discharge patients too early. For that reason good quality
control is appropriate. Another challenge implementing the
Swiss DRG is that the quality of care may decrease.
Before 2012, the reimbursement modalities for inpatient
treatment in Switzerland differed between different regions
and different states (cantons). Hospitals in some cantons
used DRG based reimbursement systems and in other hos-
pitals FFS based systems were used. This unique situation
allowed the two systems to be compared, with a hospital
for each one as proxy in a head-to-head comparison. We
have previously compared the two systems in a secondary
analysis of a former randomised-controlled trial (RCT) fo-
cusing thereby only on patients with pneumonia [11]. In
that analysis, we found LOS in DRG hospitals to be signi-
ficantly shorter compared to FFS hospitals by roughly 20%
and no differences in outcomes. The current prospective
study intended to expand these findings to other diagnoses.
Thus, within this survey study focusing on four well
defined and important medical conditions, we aimed to
compare LOS and different patient relevant outcomes
between the two systems using a hospital for each system
as proxy.
Methods
Study design, centres and setting
This was a prospective, two centre observational cohort
study at the university departments of medicine from the
University Hospital Basel and the Cantonal Hospital Aa-
rau, Switzerland, between January and June 2011. The
University Hospital Basel is a tertiary referral centre in
North-western Switzerland with 670 beds which treats
31,600 hospitalised patients a year with a fee-for-service
based reimbursement system. The Cantonal Hospital Aarau
is a tertiary referral university-affiliated hospital with 630
beds treating 26,660 inpatients per year based on AP-DRG
reimbursement.
The study protocol was approved by the two local ethical
committees, and written informed consent was waived for
this observational survey.
Selection of participants and procedures
We included all patients with a final discharge diagnosis of
(a) community-acquired pneumonia (ICD-10 codes J10.0,
J12-18), (b) acute heart failure (ICD-10 code I50), (c) ex-
acerbation of chronic obstructive pulmonary disease
(COPD; ICD-10 code J44.1) and (d) total prosthesis of the
hip (ICD-10 code S72.0-1). These diagnoses were selected
because they represent a large number of inpatients with-
in the medical and surgical spectrum. Due to the small
sample size, we collapsed community-acquired pneumonia
and COPD exacerbation into one category named “lower
respiratory tract infection”. Patients were identified with
the help of the electronic health records based on the final
medical report in each of the two hospitals. Patients who
did not survive their hospital stay were excluded, as well
as patients who were hospitalised a second time during the
study period.
Three months (range 2–4 months) after hospital discharge
we sent patients a systematic, validated questionnaire de-
scribed below asking about satisfaction with the hospital
stay and quality of life (see Appendix). To improve the re-
turn rate of the questionnaires, we re-sent it a second time
to non-responding patients.
Endpoints and outcomes
The primary endpoint of this study was LOS defined as
hospital admission until discharge. Secondary endpoints
were hospital re-admission rates and patients’ satisfaction
with the discharge procedure and quality of life. Re-admis-
sion was defined as a re-hospitalisation within three month
of hospital discharge. To assess the patient’s overall satis-
faction we used a percentage scale with a range of 0% (very
unsatisfied) to 100% (very satisfied). Quality of life was
measured with the EQ-5D instrument, which includes the
15-item tool EQ-5Dself-classifier and assesses the health re-
lated quality of life according to five dimensions (mobility,
self-care, usual activities, pain/discomfort and anxiety/de-
pression) [12, 13].
Statistics
We used mean and standard deviation, or median and in-
terquartile range to describe the population as appropriate.
To investigate differences between LOS in the two hospit-
als, we calculated a generalised linear model (GLM) with
a gamma distribution and a log link function as previously
suggested for this type of continuous, non-normally dis-
tributed outcome data [14]. This approach was preferred
over a Cox regression model due to violation of the pro-
portional hazard assumption. We adjusted the model for
the main predictors of LOS, namely age, gender, diagnosis
and co-morbidities (anaemia, CHF, COPD, diabetes, hy-
pertension, coronary heart disease, renal insufficiency, ma-
lignancy). For secondary binary endpoints, we calculated
logistic regression models adjusted for the same covariates
as described above. For other continuous outcome vari-
ables, we calculated linear regression models after ascer-
taining a roughly normal- distribution of data. Outcomes
were compared within the different diagnoses groups to
also check for consistency of effects.
Reported confidence intervals (CI) are two-sided 95% in-
tervals and tests were performed at the two-sided 5% sig-
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nificance level. All analyses were performed with STATA
9.2 (Stata Corp, College Station, Texas).
Results
Baseline characteristics
A total of 1093 patients (FFS: N = 704, AP-DRG N = 389;
s. fig. 1 and fig. 2) were identified in the database, a letter
and questionnaire were sent to 897 (82.1%) living patients,
and 450 (50.2%) returned a legible questionnaire after two
send-outs (fig. 1). This total of 450 patients who respon-
ded was included in this study; 275 (61%) were from the
FFS hospital and 175 from the DRG hospital. The ques-
tionnaires were fully completed in 79.8%; 12% had one
question missing and 8.2% two or more. The most common
diagnosis was lower respiratory tract infection (LRTI) with
48% (n = 217) which included the two diagnoses “com-
munity acquired pneumonia” and “exacerbation of chron-
ic obstructive pulmonary disease”. Acute heart failure was
present in 32.4% (AHF, n = 146) and total prosthesis of
the hip was present in 19.3% (n = 87). Median age was
77 years and was significantly higher in the FFS hospit-
al (p <0.001). A total of 48% of patients were male. Pa-
tients had a significant burden of co-morbidities, particu-
larly hypertension (27%), coronary heart disease (27.6%)
and congestive heart failure (22.2%) among others. The
two hospitals differed significantly regarding the preval-
Figure 1
Patient inclusion flow chart AP-DRG Hospital.
Figure 2
Patient inclusion flow chart FFS hospital.
ence of coronary heart disease, diabetes and chronic renal
failure with the FFS cohort showing more of these co-mor-
bidities. Table 1 shows detailed baseline characteristics for
the overall cohort, and separately for the FFS and the AP-
DRG hospitals.
Primary and secondary outcomes
Length of hospital stay
Overall, the mean LOS was 9.0 days (95%CI 8.4, 9.6).
LRTI patients had a LOS of 8.1 days (95%CI 7.2, 9.1),
while it was longer in AHF patients (9.9 days, 95%CI 8.6,
11.5) and hip replacement patients (9.7 days, 95%CI 8.8,
10.8). Overall we found shorter LOS in the AP-DRG hos-
pital as compared to the FFS hospital (unadjusted differ-
ence –0.15 days (–0.29, –0.01), p = 0.04). However, after
adjusting for the above mentioned important confounding
factors this difference did not reach statistical significance
(adjusted difference –0.07 (95%CI 0.02, –0.08), p = 0.24).
Similar results were found for LRTI and AHF patients; yet
for total hip prosthesis patients, the association was oppos-
ite with longer LOS in the AP-DRG hospital, which again
did not reach statistical significance in multivariate adjus-
ted analysis. Detailed results for the overall cohort and for
the three different diagnoses are displayed in table 2.
Re-hospitalisation and satisfaction with care
The rate of re-hospitalisation for any reason was signific-
antly higher in the FFS hospital (35% vs. 17.5%), which re-
mained significant after multivariate adjustment (p = 0.01).
Thereof, significantly more patients from the FFS hospital
were re-admitted to acute-care institutions than from the
AP-DRG hospital (11.7% vs. 5.2%, adjusted p = 0.014).
This type of re-hospitalisation may lead to surplus cost for
a hospital falling into the same budget as the primary hos-
pitalisation.
Overall satisfaction with care was high and similar in both
hospital types (86% vs. 83%). Yet, the proportion of pa-
tients not satisfied with the discharge process was signific-
antly higher in the FFS hospital (15.3% vs. 9.7%, p = 0.02).
Quality of life
We investigated quality of life as assessed with a standard-
ised questionnaire (EQ-5D) across five dimensions (mobil-
ity, self-care, usual activities, pain and depression). There
was a significantly lower proportion of patients reporting
problems with usual activities (37.9% vs. 42.4%, adjusted
odds ratio (OR) 0.55 (95%CI 0.32, 0.91), p = 0.02) and
with self-care (37.8% vs. 55.3%, OR 0.45 (95%CI 0.22,
0.93), p = 0.03) in the AP-DRG hospital compared to the
FFS hospital. For the other quality of life items, no such
difference was observed.
Discussion
The aim of the current study was to investigate differences
in patient and hospital relevant outcomes between two AP-
DRG and FFS hospitals in Switzerland, as a baseline before
a nation-wide adaption of the DRG system. The data from
our survey suggest that AP-DRG hospitals may have an
improved discharge process with higher patient satisfaction
on discharge, lower re-hospitalisation rates and shorter
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LOS. This was only partly explained by a higher burden of
co-morbidities and disease severity in FFS hospitals.
We suppose that patients in University hospitals are usually
sicker than other tertiary care centres due to higher frequen-
cies of immunosuppressed and post-transplantation pa-
Table 1: Baseline characteristics of included patients according to hospital reimbursement system.
All patients
(n = 450)
FFS hospital
(n = 275)
AP-DRG hospital
(n = 175)
p-value
Demographics
Mean age [years](±SD)* 71.1 (±19.5) 74.8 (±13.4) 65.2 (±25.3) <0.001
Male sex 214 (48%) 134 (49%) 80 (46%) 0.53
Main diagnosis 0.27
Lower respiratory Infection** 217 (48.2%) 128 (46.5%) 89 (50.9%)
Acute heart failure 146 (32.4%) 97 (35.3%) 49 (28%)
Total prosthesis of the hip 87 (19.3%) 50 (18.2%) 37 (21.1%)
Co-morbidities
Anaemia 34 (7.6%) 24 (8.7%) 10 (5.7%) 0.24
Congestive heart failure 100 (22.2%) 64 (23.3%) 36 (20.6%) 0.51
COPD 34 (7.6%) 22 (8%) 12 (6.9%) 0.7
Dementia 12 (2.7%) 9 (3.3%) 3 (1.7%) 0.30
Diabetes 58 (12.9%) 45 (16.4%) 13 (7.4%) <0.01
Hypertension 122 (27.1%) 83 (30.2%) 39 (22.3%) 0.07
Coronary heart disease 124 (27.6%) 86 (31.3%) 38 (21.7%) 0.03
Chronic renal failure 53 (11.8%) 44 (16%) 9 (5.1%) <0.01
Malignancy 27 (6%) 18 (6.5%) 9 (5.1%) 0.54
* Expressed as mean (±SD); p values refer to Mann-Whitney-U and chi-square tests ** Defined as having either community-acquired pneumonia or acute exacerbation of
chronic obstructive pulmonary disease.
Table 2: Primary and secondary endpoints with regard to hospital type.
Overall
(n = 450)
FFS hospital
(n = 275)
AP-DRG
hospital
(n = 175)
Unadjusted regression
coefficient or odds ratio
p-
value
Adjusted regression
coefficient or odds ratio †
p-
value
Length of hospital stay, mean
(IQR)
All patients 9.0 (5, 12) 9.5 (1, 30) 8.2 (1, 26) Coefficient – 0.15 (–0.29, –0.01) 0.04 Coefficient –0.07 (–0.02, 0.08) 0.24
Lower respiratory Infection 8.1 (4, 11) 8.8 (4, 12) 7.1 (3, 9) Coefficient – 0.22 (–0.44, 0.01) 0.06 Coefficient –0.09 (–0.35, 0.17) 0.49
Acute heart failure 9.9 (5, 13) 10.8 (7, 15) 8.0 (4, 11) Coefficient – 0.30 (–0.55, –0.04) 0.023 Coefficient –0.22 (-0.49, 0.06) 0.126
Total prothesis of the hip 9.7 (6-12) 8.8 (6-11) 11.0 (8, 13) Coefficient 0.23 (0.025, 0.43) 0.027 Coefficient 0.18 (–0.03, 0.39) 0.1
Re-hospitalisation for
any reason
28.4% (n =
122)
35.0% (n = 94)
‡
17.5%
(n = 28)§
OR 0.39 (0.24, 0.64) <0.01 OR 0.39 (0.22, 0.67) 0.01
Unplanned re-hospitalisation
in acute care institution
9.3% (n = 39) 11.7% (n = 31) 5.2% (n = 8) OR 0.42 (0.18, 0.92) 0.03 OR 0.31 (0.12, 0.79) 0.014
Overall satisfaction with care
(0%–100%), mean (SD)
84.7 (±24) 86 (±21) 83 (±27) Coefficient –3.1 (–7.7, 1.4) 0.2 Coefficient –3.5 (–8.4, 1.3) 0.15
Satisfaction with discharge
procedure
Not satisfied with discharge
process
13.2% (n = 53) 15.3% (n = 38) 9.7% (n = 15) OR 0.60 (0.31, 1.13) 0.11 OR 0.41 (0.20, 0.85) 0.02
Date of discharge
Too early 1.2% (n = 5) 1.6% (n = 4) 0.6% (n = 1) OR 0.40 (0.04, 3.58) 0.41 OR 0.17 (0.06, 3.97) 0.27
Too late 9.3% (n = 38) 9.5% (n = 24) 8.9% (n = 14) OR 0.93 (0.47, 1.85) 0.87 OR 0.54 (0.24, 1.20) 0.13
Quality of life (QoL according
to EQ-5D) on day 30
Any problems with mobility 45.3%
(n = 204)
44.7%
(n = 123)
46.3% (n = 81) OR 1.06 (0.70, 1.56) 0.75 OR 1.33 (0.87, 2.01) 0.20
Any problems with self-care 91.6%
(n = 412)
93.8%
(n = 258)
88.0%
(n = 154)
OR 0.48 (0.24, 0.94) 0.03 OR 0.45 (0.22, 0.93) 0.03
Any problems with usual
activities
78.0%
(n = 351)
79.3%
(n = 218)
76.0%
(n = 133)
OR 0.83 (0.53, 1.30) 0.40 OR 0.55 (0.32, 0.91) 0.02
Any problems with pain/
discomfort
54.7%
(n = 246)
54.6%
(n = 150)
54.9% (n = 96) OR 1.01 (0.69, 1.48) 0.95 OR 0.99 (0.66, 1.40) 0.94
Any problems with anxiety/
depression
33.1%
(n = 149)
33.5% (n = 92) 32.6% (n = 57) OR 0.96 (0.64, 1.40) 0.85 OR 1.01 (0.70, 1.70) 0.70
* Results are derived from generalised linear model (GLM) with a gamma distribution for LOS, logistic regression for binary outcomes and linear models for continuous
outcomes. † models adjusted for the main predictors of LOS, namely age, gender, diagnosis and co-morbidities (anaemia, CHF, COPD, diabetes, hypertension, coronary
heart disease, renal insufficiency, malignancy).OR, odds ratio, Coefficient, regression coefficient
‡ In 96.7% (266/275) of questionnaires this information was provided. § In 88% (154/175) of questionnaires this information was provided.
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tients among others. In our study this was reflected by
the higher proportion of patients with diabetes, coronary
heart disease and chronic renal failure in the tertiary centre
(FFS). Furthermore, these patients were older and had
more problems with self-care and usual activities. The con-
sequence may be that more of the patients from the FFS
institution were re-hospitalised for any reason, probably
because they were less independent and less mobile in
everyday life. The relative frequency of re-hospitalisation
to acute-care institutions was also significantly different.
This is an interesting finding because usually DRG hospit-
als are incriminated for discharging patients too early caus-
ing too many re-admissions.
Prior to 2012, the majority of Swiss hospitals used the FFS
system in order to account their inpatient services. The
main idea of this system is that the hospital gets a flat tax
for every day the patient is hospitalised. On top of this flat
rate, the hospital receives additionally a fee for every per-
formed service on the patient. The challenge of the FFS is
that neither the severity of the disease nor the related treat-
ment cost is mapped properly. Furthermore, it creates an in-
centive to hospitalise patients for too long [15].
As mentioned above, the FFS and the adapted AP-DRG
was active at the same time in Switzerland until the end of
2011. This fact provided the unique chance to compare an
AP-DRG like system and the FFS system in an otherwise
relatively homogenous society and to detect the difficulties
and differences between the said systems. With our study,
we also built the basis for further studies in that domain.
Pretto et al. (2010) conducted a study on elderly with frac-
tures before the introduction of DRGs in Switzerland [10].
As important baseline data, these studies will help to recog-
nise outcome changes after switching to DRG.
There are other studies comparing the AP-DRG and the
FFS system in Switzerland. One of them focused on pa-
tients with community-acquired pneumonia from a
randomised-controlled trial hospitalised in six centres with-
in Switzerland [11]. Unlike the current study, it detected a
significantly shorter LOS in AP-DRG hospitals compared
to FFS hospitals, which was true even after adjustment for
severity of illness. Mortality and patient satisfaction with
the discharge process were similar in both systems. Also,
quality of life was not different [11]. The current study ex-
tends these previous findings to other patient populations.
Differences in this study regarding satisfaction with dis-
charge and quality of life may be due to differences in dis-
charge processes and a higher burden of co-morbidities,
and needs further analysis.
The studies did not show a consolidated outcome in the
field of re-admission; in some it remains constant [11] and
in others there were more re-hospitalisations in the areas
with AP-DRG [16]. Our study did show a significant dif-
ference between the FFS and AP-DRG institutions regard-
ing acute care re-hospitalisations after discharge.
Busato et al. conducted a study comparing the FFS and
the AP-DRG and found the following results in the AP-
DRG areas: lower hospitalisation rates, shorter hospitalisa-
tion stays, but higher 90-day re-hospitalisation rates. Dif-
ferences to this study were that the inpatient cost weight per
1000 population was almost equal and the outpatient cost
weights lower [16]. The DRG system led to a shift from in-
patient to ambulatory treatment of patients.
The current study has several limitations. First, the use of
questionnaires after two to four months after hospital dis-
charge may well not reflect patients’ opinion due to recall-
ing difficulties. Furthermore, we recognised that some pa-
tients had several hospitalisations within a short period of
time and didn’t know which hospitalisation to refer to. In
these cases we excluded the patients to get high quality
data; this procedure and the response rate of 50% may
have introduced some selection bias. Third, not all ques-
tions were answered and in fact 12% of questionnaires did
not feature any information on re-hospitalisation in the AP-
DRG hospital (3.3% in the FFS institution). Fourth, report-
ing data from two centres in Switzerland may not be gen-
eralisable to other centres within the country or elsewhere.
Furthermore, we cannot completely exclude some centre
related confounding, as well as residual confounding ef-
fects on the patient level. Fifth, we were comparing the
data from two centres with a different case mix; the patients
in the FFS centre were sicker and showed more comor-
bidities and were less self-sufficient on discharge. The de-
scribed differences between the two centres may have in-
troduced some confounding regarding LOS and certainly
regarding impediments in everyday life. For obvious reas-
ons, we could not use cost-weights to adjust for these dif-
ferences among the two institutions.
In conclusion the current study suggests an improved dis-
charge process at the AP-DRG hospital with higher patient
satisfaction on discharge, lower re-hospitalisation rates and
shorter LOS. However, this may be partly explained by
a higher burden of co-morbidities and disease severity in
the FFE hospital. It will be interesting to monitor these
outcomes after the nation-wide DRG implementation in
Switzerland; for this purpose the presented data provide a
solid baseline.
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Figures (large format)
Figure 1
Patient inclusion flow chart AP-DRG Hospital.
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Figure 2
Patient inclusion flow chart FFS hospital.
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